Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Citi
QuintilesIMS
Federal Trade Commission
Harvard Business School
AstraZeneca
Chubb
Boehringer Ingelheim
Julphar

Generated: November 19, 2018

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: SAQUINAVIR MESYLATE

« Back to Dashboard

SAQUINAVIR MESYLATE

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Hoffmann La Roche INVIRASE saquinavir mesylate CAPSULE;ORAL 020628 NDA Genentech, Inc. 0004-0245-15 270 CAPSULE in 1 BOTTLE, PLASTIC (0004-0245-15)
Hoffmann-la Roche INVIRASE saquinavir mesylate TABLET;ORAL 021785 NDA Genentech, Inc. 0004-0244-51 120 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0004-0244-51)
Hoffmann-la Roche INVIRASE saquinavir mesylate TABLET;ORAL 021785 NDA State of Florida DOH Central Pharmacy 53808-0674-1 30 TABLET, FILM COATED in 1 BLISTER PACK (53808-0674-1)
Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
QuintilesIMS
Express Scripts
Federal Trade Commission
Cipla
McKinsey
Daiichi Sankyo
Julphar
US Department of Justice